Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Guangcheng Pharmaceutical Co., Ltd. is a pharmaceutical company based in Taizhou, China, within the China Medical City (CMC) hub. Founded in 2013, the company focuses on the research, development, production, and commercialization of chemical drugs, particularly high-end generics and improved new formulations. Its therapeutic focus includes cardiovascular diseases, metabolic disorders, and oncology. The company operates a modern manufacturing base with multiple GMP-certified production lines for solid oral dosages and active pharmaceutical ingredients (APIs). Jiangsu Guangcheng is recognized as a high-tech enterprise and a Gazelle Enterprise in the Jiangsu province, emphasizing its growth and innovation in the regional pharmaceutical landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Guangcheng.